Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGHC
2126
DELISTED
National General Holdings Corp
NGHC
| $2.65M | ﹤0.01% |
115,300
-149,500
| -56% | -$3.52M |
|
2127
Build-A-Bear
BBW
$425M
| $2.65M | ﹤0.01% |
841,966
-203,411
| -19% | -$779K |
|
2128
Biglari Holdings Class B
BH
$1.25B
| $2.65M | ﹤0.01% |
24,326
-3,936
| -14% | -$389K |
|
|
WCC
2129
WESCO International
WCC
$16.7B
| $2.65M | ﹤0.01% |
55,400
-355,800
| -87% | -$16.7M |
|
2130
MakeMyTrip
MMYT
$5.36B
| $2.65M | ﹤0.01% |
116,553
+74,400
| +176% | +$1.83M |
|
2131
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| $2.64M | ﹤0.01% |
32,600
-52,002
| -61% | -$4.2M |
|
2132
iShares MSCI Canada ETF
EWC
$6.13B
| $2.64M | ﹤0.01% |
91,300
-900
| -1% | -$25.6K |
|
|
RSX
2133
DELISTED
VanEck Russia ETF
RSX
| $2.64M | ﹤0.01% |
115,600
-51,795
| -31% | -$1.19M |
|
2134
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
| $2.63M | ﹤0.01% |
32,575
+10,928
| +50% | +$882K |
|
2135
Greif Class B
GEF.B
$4.11B
| $2.62M | ﹤0.01% |
57,510
+7,100
| +14% | +$305K |
|
|
SUNE
2136
SUNation Energy
SUNE
$8.95M
| $2.62M | ﹤0.01% |
1
| – | – |
|
2137
Parke Bancorp
PKBK
$401M
| $2.61M | ﹤0.01% |
129,377
-3,338
| -3% | -$68.8K |
|
|
PLAN
2138
DELISTED
Anaplan, Inc.
PLAN
| $2.61M | ﹤0.01% |
55,586
-211,314
| -79% | -$11.5M |
|
|
TLRA
2139
DELISTED
Telaria, Inc.
TLRA
| $2.61M | ﹤0.01% |
377,700
-991,300
| -72% | -$8.23M |
|
|
CLPR
2140
Clipper Realty
CLPR
$45.2M
| $2.6M | ﹤0.01% |
255,357
+800
| +0.3% | +$8.75K |
|
2141
Distribution Solutions Group
DSGR
$1.6B
| $2.6M | ﹤0.01% |
134,000
-40,200
| -23% | -$779K |
|
|
SFE
2142
DELISTED
Safeguard Scientifics, Inc.
SFE
| $2.59M | ﹤0.01% |
228,600
-5,200
| -2% | -$62K |
|
2143
Aware
AWRE
$26M
| $2.59M | ﹤0.01% |
866,511
+1,905
| +0.2% | +$5.69K |
|
|
CSLT
2144
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.58M | ﹤0.01% |
1,829,600
+119,400
| +7% | +$238K |
|
2145
Comp X International
CIX
$349M
| $2.58M | ﹤0.01% |
179,900
+2,700
| +2% | +$41K |
|
|
HCR
2146
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $2.58M | ﹤0.01% |
1,481,784
+1,042,381
| +237% | +$2M |
|
|
LHCG
2147
DELISTED
LHC Group LLC
LHCG
| $2.57M | ﹤0.01% |
22,669
+4,942
| +28% | +$595K |
|
2148
Data I/O
DAIO
$29.2M
| $2.57M | ﹤0.01% |
658,914
-13,128
| -2% | -$53K |
|
2149
Corvus Pharmaceuticals
CRVS
$1.12B
| $2.56M | ﹤0.01% |
851,778
+18,680
| +2% | +$78.4K |
|
|
TRCB
2150
DELISTED
Two River Bancorp
TRCB
| $2.56M | ﹤0.01% |
123,587
+24,200
| +24% | +$418K |
|
Similar funds
Renaissance Technologies's Q3 2019 Portfolio in Review
As of Q3 2019, Renaissance Technologies held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Renaissance Technologies's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Renaissance Technologies added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Renaissance Technologies's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Renaissance Technologies fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Renaissance Technologies's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Renaissance Technologies opened 406 new positions and closed 522 in Q3 2019.
- Renaissance Technologies's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.